Jupiter Neurosciences, Inc. Common Stock (JUNS) is a publicly traded Healthcare sector company. As of August 24, 2026, JUNS trades at $5.51 with a market cap of $4.77M and a P/E ratio of -22.04. JUNS moved -10.00% today. Year to date, JUNS is -92.60%; over the trailing twelve months it is -95.04%. Its 52-week range spans $4.56 to $833.25. Rallies surfaces JUNS's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies AI research for JUNS combines live market data, fundamentals, news, analyst context, hedge fund holdings, politician trades, insider activity, and risk factors into a ticker-specific research workflow.
| Metric | Value |
|---|---|
| Price | $5.51 |
| Market Cap | $4.77M |
| P/E Ratio | -22.04 |
| EPS | $-0.25 |
| Dividend Yield | 0.00% |
| 52-Week High | $833.25 |
| 52-Week Low | $4.56 |
| Volume | 604.95K |
| Avg Volume | 0 |
| Revenue (TTM) | $21.80K |
| Net Income | $-8.64M |
| Gross Margin | 0.00% |
JUNS analyst coverage data. Average price target: $0.00.